Suchergebnisse - "cisplatin"

PubPharm (73.035)

71

Ondansetron attenuates cisplatin-induced behavioral and cognitive impairment through downregulation of NOD-like receptor inflammasome pathway

enthalten in: Toxicology and applied pharmacology | 2024

von Hassan, M. | Wahdan, S. | El-Naga, R. | +2

72

Exploring the role of ghrelin and des-acyl ghrelin in chemotherapy-induced nausea and vomiting

enthalten in: Neuropharmacology | 2024

von Yang, L. | Kung, C. | Lu, Z. | +7

73

Identification of a cisplatin resistant-based prognostic immune related gene signature in MIBC

enthalten in: Translational oncology | 2024

von Wu, Y. | Xu, Z. | Fu, G. | +5

74

Fraxetin pretreatment alleviates cisplatin-induced kidney injury by antagonizing autophagy and apoptosis via mTORC1 activation

enthalten in: Phytotherapy research : PTR | 2024

von Yuan, Z. | Yang, X. | Hu, Z. | +7

75

A miRNA-7704/IL2RB/AKT feedback loop regulates tumorigenesis and chemoresistance in ovarian cancer

enthalten in: Experimental cell research | 2024

von Meng, X. | Liang, X. | Yang, S. | +2

76

PRMT4 interacts with NCOA4 to inhibit ferritinophagy in cisplatin-induced acute kidney injury

enthalten in: FASEB journal : official publication of the Federation of American Societies for Experimental Biology | 2024

von Zhou, L. | Deng, Z. | Wang, Y. | +6

77

HPLC-ESI/MS-MS metabolic profiling of white pitaya fruit and cytotoxic potential against cervical cancer : Comparative studies, synergistic effects, and molecular mechanistic approaches

enthalten in: Journal of pharmaceutical and biomedical analysis | 2024

von El-Nashar, H. | Al-Azzawi, M. | Al-Kazzaz, H. | +7

78

Jolkinolide B synergistically potentiates the antitumor activity of GPX4 inhibitors via inhibiting TrxR1 in cisplatin-resistant bladder cancer cells

enthalten in: Biochemical pharmacology | 2024

von Sang, J. | Liu, C. | Liu, J. | +7

79

Development and characterization of magnetic hydrogels loaded with greenly synthesized iron-oxide nanoparticles conjugated with cisplatin

enthalten in: Pharmaceutical development and technology | 2024

von Shammeri, A. | Abu-Huwaij, R. | Hamed, R.

80

FDA-Approved Tedizolid Phosphate Prevents Cisplatin-Induced Hearing Loss Without Decreasing Its Anti-tumor Effect

enthalten in: Journal of the Association for Research in Otolaryngology : JARO | 2024

von Yao, Z. | Xiao, Y. | Li, W. | +13